Wolverine Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3K Buy
+560
New +$9.24K ﹤0.01% 1507
2026
Q2
– Sell
-23,343
Closed -$173K – 1815
2026
Q1
$173K Buy
+23,343
New +$246K ﹤0.01% 1106
2025
Q1
– Sell
-1,133
Closed -$18.7K – 1701
2024
Q4
$18.7K Buy
+1,133
New +$17.6K ﹤0.01% 1302
2022
Q2
– Sell
-142,763
Closed -$1.73M – 2416
2022
Q1
$1.73M Buy
+142,763
New +$3M 0.02% 554

Other funds holding NEO

Wolverine Asset Management's NEO Position: Q3 2026 in Review

Wolverine Asset Management opened a new position in NeoGenomics (NEO) in Q3 2026: 560 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #1507 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in NEO as recently as Q1 2026.

Wolverine Asset Management first reported a position in NEO in Q1 2022 and has held it in 4 quarters since. The position peaked at $1.73M in Q1 2022. 297 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Wolverine Asset Management held 560 shares of NeoGenomics worth $10.3K as of Q3 2026.
  • NeoGenomics was a new Wolverine Asset Management position in Q3 2026.
  • NeoGenomics made up ﹤0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #1507 holding.
  • Wolverine Asset Management first reported a position in NeoGenomics in Q1 2022 and has held it in 4 quarters since.
  • Wolverine Asset Management's NeoGenomics position peaked at $1.73M in Q1 2022.
  • 297 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.